期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Research on the Protection of Vulnerable Groups in Water Pollution Conflicts Based on Binomial Tree Pricing Model
1
作者 Yanping Chen Tiejun Cheng fengping wu 《Journal of Water Resource and Protection》 2015年第8期659-664,共6页
The interests of vulnerable groups can’t be guaranteed due to their weaker capacity and the limited interests demand channels during the water pollution conflicts. The interest protection for the vulnerable people in... The interests of vulnerable groups can’t be guaranteed due to their weaker capacity and the limited interests demand channels during the water pollution conflicts. The interest protection for the vulnerable people in the water pollution conflicts has attracted attentions of the international scholars. The paper tries to construct the market mechanism which can make the vulnerable people to involve in the emission trading. The vulnerable people can buy American put option in the emission trading market. When the price of the emission runs below the contract price, the vulnerable people can get the benefit through executing the option. When the price of the emission runs above the contract price, the vulnerable people can give up the right. The binomial tree option pricing model can help the vulnerable people to make a decision through the analysis of the worth of the American put option. 展开更多
关键词 VULNERABLE Groups Water Pollution Conflicts Emission TRADING American PUT OPTION BINOMIAL Tree OPTION PRICING Model
暂未订购
Peripheral Blood CD4^(+)/CD8^(+)T Cell Ratio Predicts HBsAg Clearance in Inactive HBsAg Carriers Treated with Peginterferon Alpha
2
作者 fengping wu Chenrui Liu +9 位作者 Ling He Yikai Wang Xin Zhang Miaoxian Li Rui Lu Pei Kang Mei Li Yaping Li Xiaoli Jia Shuangsuo Dang 《Journal of Clinical and Translational Hepatology》 2025年第2期130-142,共13页
Background and Aims:T lymphocytes play a pivotal role in resolving hepatitis B virus infection.This study aimed to investigate the dynamics of peripheral blood T lymphocyte subsets during peginterferon alpha(peg-IFN-... Background and Aims:T lymphocytes play a pivotal role in resolving hepatitis B virus infection.This study aimed to investigate the dynamics of peripheral blood T lymphocyte subsets during peginterferon alpha(peg-IFN-α)therapy and their association with hepatitis B surface antigen(HBsAg)clearance in inactive HBsAg carriers(IHCs).Methods:This prospective observational study enrolled 197 IHCs treated with peg-IFNα-2a/2b for 48 weeks and followed for 24 weeks(treatment group),and 221 IHCs who were regularly monitored for 72 weeks without treatment(IHC control group).Peripheral blood T lymphocyte subsets were evaluated using flow cytometry at baseline,and at 12,24,48,and 72 weeks in both groups.At 72 weeks,IHCs in the treatment group were categorized into an HBsAg clearance group and an HBsAg persistence group.Differences in T lymphocyte subsets among these groups were compared,and correlations between T lymphocyte subsets and HBsAg clearance were analyzed.Results:At 72 weeks,intention-to-treat analysis showed significantly higher HBsAg clearance(46.7%)and seroconversion rates(34.5%)in the treatment group compared to the IHC control group(HBsAg clearance rate of 1.4%,seroconversion rate of 0.9%;both p<0.001).The median absolute counts of CD3^(+),CD4^(+),and CD8^(+)cells significantly decreased at 12,24,and 48 weeks in both the HBsAg clearance and persistence groups,returning to baseline at 72 weeks(all p<0.001).IHCs with HBsAg clearance had higher median percentages of CD3^(+)CD8^(+)cells and lower median percentages of CD3^(+)CD4^(+)cells and CD4^(+)/CD8^(+)ratios at 12,24,and 48 weeks compared to the HBsAg persistence and IHC control groups(all p<0.001).Baseline HBsAg levels(below 2.0 log10 IU/mL)and hepatitis B virus DNA levels(below 20 IU/mL),alanine aminotransferase elevation at 12 weeks(greater than 2×upper limit of normal),and CD4^(+)/CD8^(+)ratios(less than 1.5 at 12 weeks and below 1.4 at 24 weeks)were predictive of HBsAg clearance.Conclusions Peripheral blood CD4^(+)/CD8^(+)ratios at 12 and 24 weeks may serve as predictive markers for HBsAg clearance in IHCs treated with peg-IFN-α. 展开更多
关键词 Inactive HBsAg carriers Peginterferon alpha T lymphocyte subsets HBsAg clearance CD4^(+)/CD8^(+)ratio Predictive markers
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部